Where you find opportunities to grow

* Can't find your brand, product, service? Join BPT Marketplace

AI in Healthcare


Aigenpulse introduces novel data intelligence platform to life science markets

   by Alice Chamberlain    20

Life science and data technology innovator, Aigenpulse, is introducing a new state of-the-art data intelligence platform which is designed to expedite the drug discovery and development process. The Aigenpulse platform harnesses the latest artificial intelligence and machine learning tools to deliver advanced analytics to underpin scientific decision making.

Intelligent Health AI 2020

   by BiopharmaTrend    81
Intelligent Health AI 2020

The world's leading AI in Medicine Summit 

Intelligent Health is the only large-scale, global summit series focused purely on AI in healthcare! Our CPD accredited summits bring the global AI and health community together to advance discussions on how to apply AI and drive technological collaboration in healthcare.

OKRA smashes target of 2 million validated predictions for big Pharma, 6 months early

   by Marina Gonzalo    125
OKRA smashes target of 2 million validated predictions for big Pharma, 6 months early

Cambridge, UK, 19 June 2020 - OKRA, a leading provider of Artificial Intelligence (AI) driven analytics for Life Sciences, today hit an important milestone, delivering 2 million validated predictions so far in 2020, smashing through its yearly target in just half the expected time. This underscores OKRA’s achievements in empowering the pharmaceutical industry with explainable, real-time AI solutions.

Intelligent Health Inspired

   by BiopharmaTrend    111
Intelligent Health Inspired

The world’s largest online global summit dedicated to AI in medicine where clinicians, technologists, NGO’s and c-suite executives from all over the world come together for 3 days of exclusive talks, dynamic on-demand and live content, networking and virtual meetings to create a future where AI will revolutionize health and #saveliveswithai.

[Interview] Shaping European Life Sciences with AI

   by Andrii Buvailo    484
[Interview] Shaping European Life Sciences with AI

There is a great deal of hype and a lot of misconceptions among life science experts as to how AI can or can’t be applied in pharmaceutical research and business. Judging by the rapidly increasing number of AI-involved deals and partnerships tapped by big pharma recently, it becomes obvious that life sciences decision-makers are eager to understand what this new and disruptive technology can bring to the table, and how it can be adopted efficiently with tangible ROI.

In order to get valuable first-hand insight and new ideas about the technology and its emerging role in the life sciences industry, I have asked several questions to Dr. Loubna Bouarfa, Founder and CEO at ​OKRA Technologies ― a leading AI company for healthcare, which builds a sophisticated AI-driven engine specialized in supporting faster and more accurate decisions for life science executives and field teams. Loubna is also a member of the European Union AI High-Level Expert Group (HLEG) and the winner of several prestigious awards, such as MIT Innovator Under 35 and Forbes Top 50 European Women in Technology. Last year, OKRA was named the Best Female-Led Startup at the StartUp Europe Awards.